Q3 2023 Suven Pharmaceuticals Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to the Q3 and nine months FY23 earnings conference call of Suven Pharmaceuticals Limited. (Operator Instructions) Please note that this conference is being recorded.
I now have the conference over to Mr. Rishab Barar from CDR India. Thank you, and over to you.
Good day, everyone, and thank you for joining us on this call to discuss the Q3 and nine months FY23 earnings for Suven Pharmaceuticals. We have with us Mr. Venkat Jasti, Managing Director; and Mr. Venkatraman Sunder, Vice President, Corporate Affairs; and Mr. Subba Rao, CFO of the company.
Before we begin, I would like to mention that some statements made in today's discussion may be forward looking in nature and may involve risks and uncertainties. Documents relating to the company's performance have been mailed to you earlier.
I would now like to request Mr. Jasti to share his perspectives on the performance and outlook. Over to you, sir.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
